The verdict was related to the patent infringement lawsuit initiated by Vascular Solutions, Inc. (VASC) on May 16, 2013, which claimed that Boston Scientific’s Guidezilla guide extension catheter ...

NATICK, Mass. -- Boston Scientific Corporation has received U.S. Food and Drug Administration 510(k) clearance and CE Mark approval for the Guidezilla™ Guide Extension Catheter and has launched the ...

After extended legal proceedings, a federal appeals court reaffirmed an injunction issued in December against sales of Boston Scientific's ($BSX) Guidezilla catheter ...

WASHINGTON, April 15 (Reuters) - A U.S. appeals court on Tuesday lifted a preliminary injunction on Boston Scientific Corp's catheter product Guidezilla that had been issued by a lower court as part ...

A federal appeals court has lifted a preliminary injunction on Boston Scientific Corp.’s catheter product Guidezilla that had been issued by a lower court as part of a patent fight with Minneapolis, ...

Boston Scientific is launching its Guidezilla catheter as Vascular Solutions pursues a patent infringement lawsuit.--Courtesy of Boston Scientific Boston Scientific ...

Vascular Solutions VASC announced today that it has filed a patent infringement complaint in the U.S. District Court for the District of Minnesota against Boston Scientific Corporation BSX. The ...

MINNEAPOLIS, Dec. 9, 2013 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) announced today that the U.S. District Court for the District of Minnesota has granted Vascular Solutions' request ...

Boston Scientific Corporation ( BSX) is once again a hot topic of discussion among all financial market participants. Per the latest development, the company's Guidezilla guide extension catheter was ...

- Device Facilitates Delivery of Interventional Devices in Complex PCI Procedures NATICK, Massachusetts, July 12, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received U.S. Food ...